Inferior outcome of bone metastasis in non-small-cell-lung-cancer patients treated with epidermal growth factor receptor inhibitors

BACKGROUND: Targeted therapy has been established as the standard-of-care for patients with advanced non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations. Among patients with advanced lung cancer, 30–40% have bone metastases (BoM) at first diagnosis. However, lit...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Bone Oncol
Main Authors: Chen, Yue-Yun, Wang, Pei-Pei, Fu, Yang-, Li, Qing-, Tian, Jiang-Fang, Liu, Ting-, Lin, Zhen, Ding, Zhen-Yu
格式: Artigo
語言:Inglês
出版: Elsevier 2021
主題:
Research Paper
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC8138759/
https://ncbi.nlm.nih.gov/pubmed/34036039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbo.2021.100369
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍